These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18546270)

  • 1. Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.
    Urbanska K; Pannizzo P; Grabacka M; Croul S; Del Valle L; Khalili K; Reiss K
    Int J Cancer; 2008 Sep; 123(5):1015-24. PubMed ID: 18546270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines.
    Urbanska K; Trojanek J; Del Valle L; Eldeen MB; Hofmann F; Garcia-Echeverria C; Khalili K; Reiss K
    Oncogene; 2007 Apr; 26(16):2308-17. PubMed ID: 17016438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
    Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
    Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
    Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
    Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy.
    Zhou H; Rao J; Lin J; Yin B; Sheng H; Lin F; Zhang N; Yang L
    Oncol Rep; 2011 Jun; 25(6):1565-71. PubMed ID: 21455580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
    Zuo N; Zheng X; Liu H; Ma X
    Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
    Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.
    Kuno T; Hata K; Takamatsu M; Hara A; Hirose Y; Takahashi S; Imaida K; Tanaka T
    Int J Mol Sci; 2014 May; 15(5):9160-72. PubMed ID: 24857924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
    Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
    Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
    Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
    Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
    Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
    Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
    Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
    Grabacka M; Plonka PM; Urbanska K; Reiss K
    Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate induces PPARα and BMP2 expression to stimulate osteoblast differentiation.
    Kim YH; Jang WG; Oh SH; Kim JW; Lee MN; Song JH; Yang JW; Zang Y; Koh JT
    Biochem Biophys Res Commun; 2019 Dec; 520(2):459-465. PubMed ID: 31607484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
    Huang YC; Liu KC; Chiou YL; Yang CH; Chen TH; Li TT; Liu LL
    Chem Biol Interact; 2013 Oct; 205(3):157-64. PubMed ID: 23872139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
    Wang W; Lin Q; Lin R; Zhang J; Ren F; Zhang J; Ji M; Li Y
    Exp Cell Res; 2013 Jun; 319(10):1523-33. PubMed ID: 23603572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro.
    Majeed Y; Upadhyay R; Alhousseiny S; Taha T; Musthak A; Shaheen Y; Jameel M; Triggle CR; Ding H
    Sci Rep; 2019 Apr; 9(1):6316. PubMed ID: 31004117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.